These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 28412027)

  • 21. Impact of surgeon volume on the morbidity and costs of radical cystectomy in the USA: a contemporary population-based analysis.
    Leow JJ; Reese S; Trinh QD; Bellmunt J; Chung BI; Kibel AS; Chang SL
    BJU Int; 2015 May; 115(5):713-21. PubMed ID: 24674655
    [TBL] [Abstract][Full Text] [Related]  

  • 22. National Trends and Impact of Regionalization of Radical Cystectomy on Survival Outcomes in Patients with Muscle Invasive Bladder Cancer.
    Herrera JC; Ibilibor C; Wang H; Klein GT; Elshabrawy A; Chowdhury WH; Kaushik D; Liss M; Svatek R; Mansour AM
    Clin Genitourin Cancer; 2020 Dec; 18(6):e762-e770. PubMed ID: 32641262
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Radical cystectomy in the elderly: national trends and disparities in perioperative outcomes and quality of care.
    Roghmann F; Sukumar S; Ravi P; Trinh VQ; Meskawi M; Ghani KR; Sammon JD; Friedman AA; Peabody JO; Menon M; Noldus J; Karakiewicz PI; Sun M; Trinh QD
    Urol Int; 2014; 92(1):27-34. PubMed ID: 24052104
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The regionalization of radical cystectomy to specific medical centers.
    Hollenbeck BK; Taub DA; Miller DC; Dunn RL; Montie JE; Wei JT
    J Urol; 2005 Oct; 174(4 Pt 1):1385-9; discussion 1389. PubMed ID: 16145443
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Centralisation of radical cystectomies for bladder cancer in England, a decade on from the 'Improving Outcomes Guidance': the case for super centralisation.
    Afshar M; Goodfellow H; Jackson-Spence F; Evison F; Parkin J; Bryan RT; Parsons H; James ND; Patel P
    BJU Int; 2018 Feb; 121(2):217-224. PubMed ID: 28594471
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Exploring the burden of inpatient readmissions after major cancer surgery.
    Stitzenberg KB; Chang Y; Smith AB; Nielsen ME
    J Clin Oncol; 2015 Feb; 33(5):455-64. PubMed ID: 25547502
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Adherence to surveillance guidelines after radical cystectomy: a population-based analysis.
    Ehdaie B; Atoria CL; Lowrance WT; Herr HW; Bochner BH; Donat SM; Dalbagni G; Elkin EB
    Urol Oncol; 2014 Aug; 32(6):779-84. PubMed ID: 24935876
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Is there a relationship between leapfrog volume thresholds and perioperative outcomes after radical cystectomy?
    Sun M; Ravi P; Karakiewicz PI; Sukumar S; Sammon J; Bianchi M; Shariat SF; Jeong W; Ghani KR; Hansen J; Friedman A; Perrotte P; Peabody JO; Menon M; Trinh QD
    Urol Oncol; 2014 Jan; 32(1):27.e7-13. PubMed ID: 23403162
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Contemporary 90-day mortality rates after radical cystectomy in the elderly.
    Schiffmann J; Gandaglia G; Larcher A; Sun M; Tian Z; Shariat SF; McCormack M; Valiquette L; Montorsi F; Graefen M; Saad F; Karakiewicz PI
    Eur J Surg Oncol; 2014 Dec; 40(12):1738-45. PubMed ID: 25454826
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The centralization of bladder cancer care and its implications for patient travel distance.
    Pekala KR; Yabes JG; Bandari J; Yu M; Davies BJ; Sabik LM; Kahn JM; Jacobs BL
    Urol Oncol; 2021 Dec; 39(12):834.e9-834.e20. PubMed ID: 34162498
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Socioeconomic status is associated with urinary diversion utilization after radical cystectomy for bladder cancer.
    Maurice MJ; Kim SP; Abouassaly R
    Int Urol Nephrol; 2017 Jan; 49(1):77-82. PubMed ID: 27696214
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Propensity-matched comparison of morbidity and costs of open and robot-assisted radical cystectomies: a contemporary population-based analysis in the United States.
    Leow JJ; Reese SW; Jiang W; Lipsitz SR; Bellmunt J; Trinh QD; Chung BI; Kibel AS; Chang SL
    Eur Urol; 2014 Sep; 66(3):569-76. PubMed ID: 24491306
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Exploring the 3 A's of cystectomy access to care for muscle-invasive bladder cancer.
    Spencer ES; Smith AB
    Urol Oncol; 2015 Mar; 33(3):105-7. PubMed ID: 25579780
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of Hospital and Surgeon Case Volume on Perioperative Quality of Care and Short-term Outcomes After Radical Cystectomy for Muscle-invasive Bladder Cancer: Results From a European Tertiary Care Center Cohort.
    Vetterlein MW; Meyer CP; Leyh-Bannurah SR; Mayr R; Gierth M; Fritsche HM; Burger M; Keck B; Wullich B; Martini T; Bolenz C; Pycha A; Hanske J; Roghmann F; Noldus J; Bastian PJ; Gilfrich C; May M; Rink M; Chun FK; Dahlem R; Fisch M; Aziz A;
    Clin Genitourin Cancer; 2017 Oct; 15(5):e809-e817. PubMed ID: 28550955
    [TBL] [Abstract][Full Text] [Related]  

  • 35. National comparison of oncologic quality indicators between open and robotic-assisted radical cystectomy.
    Matulewicz RS; DeLancey JO; Manjunath A; Tse J; Kundu SD; Meeks JJ
    Urol Oncol; 2016 Oct; 34(10):431.e9-431.e15. PubMed ID: 27264169
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Differential effect on survival of pelvic lymph node dissection at radical cystectomy for muscle invasive bladder cancer.
    Larcher A; Sun M; Schiffmann J; Tian Z; Shariat SF; McCormack M; Saad F; Fossati N; Abdollah F; Briganti A; Buffi N; Graefen M; Guazzoni G; Montorsi F; Karakiewicz PI
    Eur J Surg Oncol; 2015 Mar; 41(3):353-60. PubMed ID: 25477269
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Predictors of preoperative delays before radical cystectomy for bladder cancer in Quebec, Canada: a population-based study.
    Santos F; Dragomir A; Kassouf W; Franco EL; Aprikian A
    BJU Int; 2015 Mar; 115(3):389-96. PubMed ID: 24656061
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Volume, process of care, and operative mortality for cystectomy for bladder cancer.
    Hollenbeck BK; Wei Y; Birkmeyer JD
    Urology; 2007 May; 69(5):871-5. PubMed ID: 17482924
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Factors influencing aggressive therapy for bladder cancer: an analysis of data from the SEER program.
    Konety BR; Joslyn SA
    J Urol; 2003 Nov; 170(5):1765-71. PubMed ID: 14532772
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Sharpening the focus on causes and timing of readmission after radical cystectomy for bladder cancer.
    Hu M; Jacobs BL; Montgomery JS; He C; Ye J; Zhang Y; Brathwaite J; Morgan TM; Hafez KS; Weizer AZ; Gilbert SM; Lee CT; Lavieri MS; Helm JE; Hollenbeck BK; Skolarus TA
    Cancer; 2014 May; 120(9):1409-16. PubMed ID: 24477968
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.